UTHR

SEC source: 0001415889-23-013515 · form4-09222023_040901.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,049

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $221.85 to $222.735. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-013515 · form4-09222023_040901.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,999

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $220.85 to $221.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-013515 · form4-09222023_040901.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-013303 · form4-09152023_040901.xml · nonDerivative · entry 1

Mesa Nilda · CIK 0001756697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,303

SEC source: 0001415889-23-013118 · form4-09082023_040904.xml · derivative · entry 5

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,000

Underlying: Common Stock · 6,000 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-013118 · form4-09082023_040904.xml · nonDerivative · entry 4

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $223.90 to $223.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-013118 · form4-09082023_040904.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,847

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $222.88 to $223.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-013118 · form4-09082023_040904.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,847

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $221.845 to $222.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-013118 · form4-09082023_040904.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-012408 · form4-08182023_040805.xml · derivative · entry 4

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

SEC source: 0001415889-23-012408 · form4-08182023_040805.xml · nonDerivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,684

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

SEC source: 0001415889-23-012408 · form4-08182023_040805.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

SEC source: 0001415889-23-012407 · form4-08182023_040801.xml · derivative · entry 6

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,000

Underlying: Common Stock · 6,000 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-012407 · form4-08182023_040801.xml · nonDerivative · entry 5

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $230.85 to $231.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-012407 · form4-08182023_040801.xml · nonDerivative · entry 4

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,200

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $229.83 to $230.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-012407 · form4-08182023_040801.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,300

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $228.81 to $229.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-012407 · form4-08182023_040801.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,700

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $227.43 to $228.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-012407 · form4-08182023_040801.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · derivative · entry 9

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,000

Underlying: Common Stock · 6,000 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 8

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F8 · price: This transaction was executed in multiple trades at prices ranging from $242.57 to $243.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 7

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,899

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F7 · price: This transaction was executed in multiple trades at prices ranging from $241.40 to $241.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 6

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,899

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F6 · price: This transaction was executed in multiple trades at prices ranging from $239.94 to $240.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 5

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,299

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $238.10 to $238.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 4

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $236.50 to $237.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,199

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $233.22 to $234.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,340

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $232.22 to $233.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-23-011859 · form4-08042023_040801.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

SEC source: 0001415889-23-011410 · form4-07242023_040702.xml · derivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

SEC source: 0001415889-23-011410 · form4-07242023_040702.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

SEC source: 0001415889-23-011410 · form4-07242023_040702.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,099

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

SEC source: 0001415889-23-011149 · form4-07172023_060706.xml · derivative · entry 2

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 900 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-011149 · form4-07172023_060706.xml · derivative · entry 1

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,280

Underlying: Common Stock · 2,280 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011158 · form4-07172023_060722.xml · derivative · entry 1

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F2 · shares: Annual non-employee director award.

F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-011157 · form4-07172023_060720.xml · derivative · entry 1

Giltner Richard · CIK 0001460472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F2 · shares: Annual non-employee director award.

F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-011156 · form4-07172023_060718.xml · derivative · entry 1

MAXWELL LINDA · CIK 0001822674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

Underlying: Common Stock · 4,560 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011154 · form4-07172023_060715.xml · derivative · entry 1

CAUSEY CHRISTOPHER · CIK 0001237334 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

Underlying: Common Stock · 4,560 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011155 · form4-07172023_060716.xml · derivative · entry 1

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

Underlying: Common Stock · 4,560 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011153 · form4-07172023_060713.xml · derivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

Underlying: Common Stock · 4,560 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011152 · form4-07172023_060711.xml · derivative · entry 1

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

Underlying: Common Stock · 4,560 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011151 · form4-07172023_060709.xml · derivative · entry 2

Mesa Nilda · CIK 0001756697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 900 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-011151 · form4-07172023_060709.xml · derivative · entry 1

Mesa Nilda · CIK 0001756697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,280

Underlying: Common Stock · 2,280 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011150 · form4-07172023_060708.xml · derivative · entry 2

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 900 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-011150 · form4-07172023_060708.xml · derivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,280

Underlying: Common Stock · 2,280 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-011148 · form4-07172023_060702.xml · derivative · entry 2

Klein Katherine J · CIK 0001625073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 900 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-011148 · form4-07172023_060702.xml · derivative · entry 1

Klein Katherine J · CIK 0001625073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,280

Underlying: Common Stock · 2,280 shares

Expires 2033-07-13

F1 · shares: Annual non-employee director award.

F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

SEC source: 0001415889-23-010949 · form4-07072023_040710.xml · derivative · entry 2

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 880 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-010949 · form4-07072023_040710.xml · nonDerivative · entry 1

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F1 · price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

SEC source: 0001415889-23-010952 · form4-07072023_040717.xml · derivative · entry 2

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 880 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.

SEC source: 0001415889-23-010952 · form4-07072023_040717.xml · nonDerivative · entry 1

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,060

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F1 · price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

SEC source: 0001415889-23-010953 · form4-07072023_040719.xml · derivative · entry 4

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 880 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock.

F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date.